Advertisement

Related Videos

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

Deborah Collyar: What's In It for Patients?

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

Advertisement

Advertisement




Feb
27
Today In Oncology
‘Prostate Screening Saved My Life’—Is That Really True In Most Cases?
SABCS 2025: Top Picks From a Breast Cancer Specialist
Intravesical Immunotherapy Shows Recurrence Control in BCG-Unresponsive Papillary-Only Non–Muscle-Invasive Bladder Cancer
How the Outlook on Fertility Preservation for Patients With Cancer Is Improving
Advanced Nonsquamous NSCLC FDA Grants Accelerated Approval to Zongertinib
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo